Great timing re the acquisition of the 49% they didn't own. Obviously not a coincidence.A great win, it is up a bit today, always good to take.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential